Surgical ablation, left atrial appendage occlusion or both? Nationwide registry analysis of cardiac surgery patients with underlying atrial fibrillation

Michał Pasierski,Jakub Batko,Łukasz Kuźma,Wojciech Wańha,Marek Jasiński,Kazimierz Widenka,Marek Deja,Krzysztof Bartuś,Tomasz Hirnle,Wojciech Wojakowski,Roberto Lorusso,Zdzisław Tobota,Bohdan J Maruszewski,Piotr Suwalski,Mariusz Kowalewski,Lech Anisimowicz,Krzysztof Bartuś,Andrzej Biederman,Dariusz Borkowski,Mirosław Brykczyński,Paweł Bugajski,Marian Burysz,Paweł Cholewiński,Romuald Cichoń,Marek Cisowski,Marek Deja,Antoni Dziatkowiak,Tadeusz Gburek,Witold Gerber,Leszek Gryczko,Ireneusz Haponiuk,Piotr Hendzel,Tomasz Hirnle,Stanisław Jabłonka,Krzysztof Jarmoszewicz,Jarosław Jasiński,Marek Jasiński,Ryszard Jaszewski,Marek Jemielity,Ryszard Kalawski,Bogusław Kapelak,Maciej A Karolczak,Jacek Kaperczak,Piotr Knapik,Michał Krejca,Wojciech Kustrzycki,Mariusz Kuśmierczyk,Paweł Kwinecki,Leszek Markuszewski,Bohdan Maruszewski,Maurycy Missima,Jacek J Moll,Wojciech Ogorzeja,Jacek Pająk,Michał Pasierski,Wojciech Pawliszak,Edward Pietrzyk,Grzegorz Religa,Jan Rogowski,Jacek Różański,Jerzy Sadowski,Girish Sharma,Janusz Skalski,Jacek Skiba,Ryszard Stanisławski,Janusz Stążka,Sebastian Stec,Piotr Stępiński,Grzegorz Suwalski,Kazimierz Suwalski,Piotr Suwalski,Łukasz Tułecki,Kazimierz Widenka,Waldemar Wierzba,Michał Wojtalik,Stanisław Woś,Michał Oskar Zembala,Piotr Żelazny

DOI: https://doi.org/10.1093/ejcts/ezae014

IF: 4.534

2024-01-13

European Journal of Cardio-Thoracic Surgery

Abstract:Abstract OBJECTIVES The aim of this study was to evaluate in-hospital outcomes and long-term survival of patients undergoing cardiac surgery with preoperative atrial fibrillation. We compared different strategies, including no atrial fibrillation treatment, left atrial appendage occlusion alone, concomitant surgical ablation alone or both. METHODS A retrospective analysis using the KROK registry included all patients with preoperative diagnosis of atrial fibrillation who underwent cardiac surgery in Poland between between January 2012 and December 2022. Risk adjustment was performed using regression analysis with inverse probability weighting of propensity scores. We assessed six-year survival with Cox proportional hazards models. Sensitivity analysis was performed based on index cardiac procedure. RESULTS Initially, 42,510 patients with preoperative atrial fibrillation were identified, and, after exclusion, 33,949 included in the final analysis. 1,107 (3.26%) received both surgical ablation and left atrial appendage occlusion, 1,484 (4.37%) received left atrial appendage occlusion alone, 3,921 (11.55%) surgical ablation alone and the remaining 27,437 (80.82%) had no atrial fibrillation directed treatment. As compared to no treatment, all strategies were associated with survival benefit over 6-years follow-up. A gradient of treatment was observed with the highest benefit associated with surgical ablation + left atrial appendage occlusion followed by surgical ablation alone and left atrial appendage occlusion alone (log-rank P < 0.001). Mortality benefits were reflected when stratified by surgery type with the exception of aortic valve surgery where left atrial appendage occlusion alone fare worse than no treatment. CONCLUSIONS Among patients with preoperative atrial fibrillation undergoing cardiac surgery, surgical management of atrial fibrillation, particularly surgical ablation+ left atrial appendage occlusion, was associated with lower six-year mortality. These findings support the benefits of incorporating surgical ablation and left atrial appendage occlusion in the management of atrial fibrillation during cardiac surgery.

surgery,cardiac & cardiovascular systems,respiratory system